Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 3,350.00
+55.00 (1.67%)
Jul 21, 2026, 2:40 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 151.72 billion as of July 20, 2026. Its market cap has increased by 8.21% in one year.
Market Cap
151.72B
Enterprise Value
70.67B
Revenue
2.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,350.00
ChartMarket Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 151.72B, a decrease of -36.42%. That is a compound annual growth rate of -2.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 151.72B | -47.03% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 265.95B |
| BINEX | 214.65B |
| EASY BIO,Inc. | 208.09B |
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| JETEMA, | 165.93B |
| Bioneer | 160.02B |